Medicine
Human Albumin Grifols 20 g/100 mL injection
Human Albumin Grifols 20 g/100 mL injection is a prescription medicine containing Albumin human for intravenous use, marketed by Grifols, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Protect from freezing. Human Albumin Grifols 20% is stable for three years…
Key facts
- Active ingredient (INN)
- Albumin human
- Brand
- Human Albumin Grifols
- Strength
- 20 g/100 mL
- Dosage form
- Injection
- Route
- Intravenous
- Packs
- 1 vial of 100 mL
- Marketing authorisation holder
- Grifols
- Manufacturer
- Grifols
- Origin register
- US FDA, United States
- Storage
- Protect from freezing. Human Albumin Grifols 20% is stable for three years provided the storage temperature does not exceed 30 °C.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- HS code (indicative)
- 3002.12Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 17 February 1995
- Identifiers
- RxCUI 1741295, 1741304DailyMed set ID a43c5ed6-7423-4ee5-8acb-5fccc2d7b6ccNDC 61953-0001Application BLA103352
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 vial in 1 carton / 100 mL in 1 vial | 61953-0001-2 | Grifols | 17 February 1995 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 31 December 1997 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Albumin human 20 g/100 mL injection.
Other strengths and forms of Albumin human
Clinical summary
Albumin human is a human serum albumin indicated for hypovolemia and Hypoalbuminemia, among other approved uses. It is available as injection for intravenous use. MedsAcross supplies Albumin human for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Albumin humanFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- KEDBUMIN prescribing information (Kedrion Sp A) · U.S. National Library of Medicine, DailyMed
Need Human Albumin Grifols 20 g/100 mL injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.